4//SEC Filing
Robinson Byron 4
Accession 0001209191-24-000438
CIK 0001817713other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:53 PM ET
Size
5.6 KB
Accession
0001209191-24-000438
Insider Transaction Report
Form 4
Robinson Byron
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-02+151,500→ 151,500 totalExercise: $11.02Exp: 2034-01-01→ Common Stock (151,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2025 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001914899
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:53 PM ET
- Size
- 5.6 KB